Blazsek I, Comisso M, Misset J L
Service des Maladies Sanguines et Tumorales, Hôpital Paul-Brousse, Villejuif, France.
Biomed Pharmacother. 1991;45(2-3):81-6. doi: 10.1016/0753-3322(91)90126-e.
Bestatin (ubenimex), the microbial leucil-aminopeptidase B inhibitor, has been shown previously to stimulate both interleukin-1 (IL-1) and IL-2 production and to enhance T-cell, as well as macrophage mediated immunoreaction when administered in vivo in mice. Here we show that although Bestatin has no direct growth stimulatory activity, it enhances the growth of GM-CFU populations in semisolide culture and stimulates the cell production in liquide organotypic Hematon cultures in synergy with recombinant human GM-CSF. In long term human bone marrow culture Bestatin accelerated the adipocytic differentiation among colony forming stroma cells (F-CFU). Our data provide further evidences that Bestatin may interact with the hemopoietic cell renewal system at different levels of biological organisation.
贝司他汀(乌苯美司)是一种微生物亮氨酰氨基肽酶B抑制剂,先前已表明,在小鼠体内给药时,它能刺激白细胞介素-1(IL-1)和IL-2的产生,并增强T细胞以及巨噬细胞介导的免疫反应。在此我们表明,尽管贝司他汀没有直接的生长刺激活性,但它能增强半固体培养中GM-CFU群体的生长,并与重组人GM-CSF协同刺激液体器官型造血培养中的细胞产生。在长期人类骨髓培养中,贝司他汀加速了集落形成基质细胞(F-CFU)中的脂肪细胞分化。我们的数据进一步证明,贝司他汀可能在生物组织的不同水平上与造血细胞更新系统相互作用。